DEVELOPMENT OF ASSAYS FOR DETECTING DRG-DRUG INTERACTION EFFECTS AND DS (Q2035312): Difference between revisions

From EU Knowledge Graph
Jump to navigation Jump to search
(‎Removed claims)
(‎Changed an Item: The budget was changed)
Property / budget
 
617,510.07 Euro
Amount617,510.07 Euro
UnitEuro
Property / budget: 617,510.07 Euro / rank
 
Normal rank
Property / EU contribution
 
297,777.75 Euro
Amount297,777.75 Euro
UnitEuro
Property / EU contribution: 297,777.75 Euro / rank
 
Normal rank
Property / co-financing rate
 
48.22 percent
Amount48.22 percent
Unitpercent
Property / co-financing rate: 48.22 percent / rank
 
Normal rank

Revision as of 09:05, 12 February 2022

Project Q2035312 in Italy
Language Label Description Also known as
English
DEVELOPMENT OF ASSAYS FOR DETECTING DRG-DRUG INTERACTION EFFECTS AND DS
Project Q2035312 in Italy

    Statements

    0 references
    297,777.75 Euro
    0 references
    617,510.07 Euro
    0 references
    48.22 percent
    0 references
    13 December 2016
    0 references
    6 July 2019
    0 references
    FONDAZIONE ISTITUTO ITALIANO DI TECNOLOGIA
    0 references
    GENECHRON S.R.L.
    0 references
    0 references
    0 references
    0 references

    41°53'35.95"N, 12°28'58.55"E
    0 references
    IL PROGETTO DIHETOX NASCE DALL'ESIGENZA DI IDENTIFICARE E VALIDARE BIOMARCATORI A RNA (MIRNA O MRNA) IN GRADO DI RILEVARE PRECOCEMENTE LA PRESENZA DI DANNO AL FEGATO INDOTTO DA FARMACI O DRUG-INDUCED LIVER INJURY (DILI) (Italian)
    0 references
    THE DIETOX PROJECT STEMS FROM THE NEED TO IDENTIFY AND VALIDATE BIOMARKERS FOR RNA (MIRNA OR MRNA) ABLE TO DETECT EARLY LIVER DAMAGE CAUSED BY DRUGS OR DRUG-INDUSTRY (DILI) (English)
    0 references
    LE PROJET DIHETOX DÉCOULE DE LA NÉCESSITÉ D’IDENTIFIER ET DE VALIDER LES BIOMARQUEURS À L’ARN (MIRNA OU MRNA) CAPABLES DE DÉTECTER RAPIDEMENT LA PRÉSENCE DE LÉSIONS HÉPATIQUES INDUITES PAR LE MÉDICAMENT OU DE LÉSIONS HÉPATIQUES INDUITES PAR LE MÉDICAMENT (DILI). (French)
    16 December 2021
    0 references
    HET DIHETOX-PROJECT VLOEIT VOORT UIT DE NOODZAAK OM BIOMARKERS TE IDENTIFICEREN EN TE VALIDEREN AAN RNA (MIRNA OF MRNA) IN STAAT OM VROEGTIJDIG DE AANWEZIGHEID VAN GENEESMIDDEL GEÏNDUCEERDE LEVERSCHADE OF DRUG-GEÏNDUCEERDE LEVERBESCHADIGING (DILI) OP TE SPOREN. (Dutch)
    23 December 2021
    0 references
    DAS DIHETOX-PROJEKT ERGIBT SICH AUS DER NOTWENDIGKEIT, BIOMARKER FÜR RNA (MIRNA ODER MRNA) ZU IDENTIFIZIEREN UND ZU VALIDIEREN, DIE IN DER LAGE SIND, FRÜHZEITIG DAS VORHANDENSEIN DROGENBEDINGTER LEBERSCHÄDEN ODER MEDIKAMENTINDUZIERTER LEBERSCHÄDEN (DILI) ZU ERKENNEN. (German)
    24 December 2021
    0 references
    EL PROYECTO DIHETOX SURGE DE LA NECESIDAD DE IDENTIFICAR Y VALIDAR BIOMARCADORES DE ARN (MIRNA O ARNM) CAPACES DE DETECTAR PRECOZMENTE LA PRESENCIA DE DAÑO HEPÁTICO INDUCIDO POR FÁRMACOS O LESIÓN HEPÁTICA INDUCIDA POR MEDICAMENTOS (DILI) (Spanish)
    25 January 2022
    0 references
    ROMA
    0 references

    Identifiers

    F87H18000400007
    0 references